Literature DB >> 17604123

Identification and characterization of equine granzyme B.

Konrad Piuko1, Ignacio G Bravo, Martin Müller.   

Abstract

In the present study we describe the isolation and characterization of putative equine granzyme B for which we propose the designation 'eqGrzmB'. Sequence analysis revealed characteristic features of a GrzmB protease such as the presence of a signal (leader-) peptide and an activation di-peptide. The isolated eqGrzmB is functionally active when expressed in human or in insect cells. Furthermore, exchange of any of three putative active site amino acids, which are highly conserved along granzyme B enzymes, led to a complete loss of enzymatic activity in the newly identified eqGrzmB. Phylogenetic analysis places eqGrzmB in the chymase-locus within the large family of granzymes in close proximity to putative equine mast cell protease and to granzyme B from mouse, rat, and human. eqGrzmB proteolytic activity has been kinetically characterized and can be specifically inhibited by granzyme B inhibitors. Taken together, we conclude that we have isolated a new member of the granzyme B family, the first granzyme identified in Equidae. The description of equine granzyme B might facilitate the development of immunological assays for the activity of equine lymphocytes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17604123     DOI: 10.1016/j.vetimm.2007.05.002

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  2 in total

1.  Granzyme B Is an Essential Mediator in CD8+ T Cell Killing of Theileria parva-Infected Cells.

Authors:  Jie Yang; Alan Pemberton; W Ivan Morrison; Tim Connelley
Journal:  Infect Immun       Date:  2018-12-19       Impact factor: 3.441

2.  Expression of endometrial immune-related genes possibly functioning during early pregnancy in the mare.

Authors:  Yurika Tachibana; Yasuko Nakano; Kentaro Nagaoka; Masato Kikuchi; Yasuo Nambo; Shingo Haneda; Motozumi Matsui; Yo-Ichi Miyake; Kazuhiko Imakawa
Journal:  J Reprod Dev       Date:  2012-11-09       Impact factor: 2.214

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.